Go AS, Mozaffarian D, Roger VL, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association. Circulation. 2013;127:143-152. Abstract
Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005;45:1397-1405. Abstract
Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol. 2004;93:629-632. Abstract
Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation. 2012;125:1501-1510. Abstract
Epstein AE, DiMarco JP, Ellenbogen KA, et al; Writing Committee Members; ACC/AHA Task Force Members. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Circulation. 2008;117:e350-408. Abstract
Rassi AN, Cavender MA, Fonarow GC, et al. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. J Am Coll Cardiol. 2013;61:35-40. Abstract
Hohnloser SH, Kuck KH, Dorian P, et al; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488. Abstract
Moss AJ, Hall WJ, Cannom DS, et al; for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940. Abstract
Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890. Abstract
Centers for Medicare and Medicaid Services. Department of Health and Human Services. CMS Manual System, Pub. 100-03 Medicare National Coverage Determinations. http://www.cms.gov/transmittals/downloads/R29NCD.pdf. Published March 4, 2005. Accessed February 8, 2013.

CME

Ischemic Heart Disease: Mitigating the Risk of Sudden Cardiac Death

Authors: Deepak L. Bhatt, MD, MPH; Roxana Mehran, MD; William S. Weintraub, MD
CME Released: 2/26/2013; Reviewed and Renewed: 9/2/2015
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 9/2/2016, 11:59 PM EST

Target Audience and Goal Statement

This activity is intended for electrophysiologists, interventional cardiologists, clinical cardiologists, and other allied healthcare professionals.

The goal of this activity is to enhance the ability to risk stratify patients at risk for sudden cardiac death immediately after percutaneous coronary intervention (PCI) so as to apply appropriate therapy.

Upon completion of this activity, participants will be able to:

Review the derivation of the CADILLAC risk score recognizing the risk factors for sudden cardiac death after PCI
Review data examining mortality risk after PCI
Identify treatment strategies to prevent sudden cardiac death in vulnerable patients following PCI

Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Authors

Deepak L. Bhatt, MD, MPH

Chief of Cardiology, VA Boston Healthcare System; Senior Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts

Disclosures

Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Amarin Corporation plc; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Ethicon, Inc.; Medtronic, Inc.; Sanofi; The Medicines Company

Dr Bhatt does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Bhatt does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Roxana Mehran, MD

Professor of Medicine and Health Policy; Director, Interventional Cardiovascular Research and Clinical Trials, The Mount Sinai Medical Center, New York, New York

Disclosures

Disclosure: Roxana Mehran, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; AstraZeneca Pharmaceuticals LP; Maya Medical, Inc.; Merck & Co., Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Regado Biosciences
Received grants for clinical research from: Bristol-Myers Squibb Company; Sanofi; The Medicines Company; Lilly USA, LLC; Daiichi Sankyo, Inc.

Dr Mehran does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Mehran does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

William S. Weintraub, MD, FACC

John H. Ammon Chair, Section of Cardiology; Director, Christiana Center for Outcomes Research, Christiana Care Health System, Newark, Delaware

Disclosures

Disclosure: William S. Weintraub, MD, has disclosed no relevant financial relationships.

Dr Weintraub does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

Dr Weintraub does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

Ronald K. Miller, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

Acute MI Steering Committee

Deepak L. Bhatt, MD, MPH

Disclosures

As listed above.

Roberta C. Bogaev, MD

Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas; Private Practice Cardiologist, Schnitzler Cardiovascular Consultants, San Antonio, Texas

Disclosures

Disclosure: Roberta C. Bogaev, MD, has disclosed no relevant financial relationships.

Ted E. Feldman, MD

Professor of Medicine, Northwestern University School of Medicine, Evanston, Illinois

Disclosures

Disclosure: Ted E. Feldman, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific; Coherex Medical, Inc.; Edwards Lifesciences; Intervalve; Daiichi Sankyo, Inc.; Lilly USA, LLC; W.L. Gore & Associates, Inc.
Served as a speaker or a member of a speakers bureau for: Boston Scientific
Received grants for clinical research from: Abbott Laboratories; Boston Scientific; Edwards Lifesciences; St. Jude Medical; W.L. Gore & Associates, Inc.

Jagmeet P. Singh, MD, PhD

Associate Professor of Medicine, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center, Harvard Medical School, Boston, Massachusetts

Disclosures

Disclosure: Jagmeet P. Singh, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BIOTRONIK; Boston Scientific; Medtronic, Inc.; St. Jude Medical; Sorin Group; CardioInsight Technologies Inc.; Thoratec Corporation
Served as a speaker or a member of a speakers bureau for: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group
Received grants for clinical research from: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group; Medtronic, Inc.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Cardiology

CME

Ischemic Heart Disease: Mitigating the Risk of Sudden Cardiac Death

Authors: Deepak L. Bhatt, MD, MPH; Roxana Mehran, MD; William S. Weintraub, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 2/26/2013; Reviewed and Renewed: 9/2/2015

Valid for credit through: 9/2/2016, 11:59 PM EST

processing....

The audio version of this presentation is available for use as a professional resource from Medscape Education.

Download Now

CME Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

References

Faculty and Disclosures

Authors

Deepak L. Bhatt, MD, MPH

Roxana Mehran, MD

William S. Weintraub, MD, FACC

Editor

Ronald K. Miller, PhD

Acute MI Steering Committee

Deepak L. Bhatt, MD, MPH

Roberta C. Bogaev, MD

Ted E. Feldman, MD

Jagmeet P. Singh, MD, PhD

CME Reviewer(s)

Nafeez Zawahir, MD

CME

Ischemic Heart Disease: Mitigating the Risk of Sudden Cardiac Death

Target Audience and Goal Statement

Disclosures

Authors

Deepak L. Bhatt, MD, MPH

Roxana Mehran, MD

William S. Weintraub, MD, FACC

Editor

Ronald K. Miller, PhD

Acute MI Steering Committee

Deepak L. Bhatt, MD, MPH

Roberta C. Bogaev, MD

Ted E. Feldman, MD

Jagmeet P. Singh, MD, PhD

CME Reviewer(s)

Nafeez Zawahir, MD

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Ischemic Heart Disease: Mitigating the Risk of Sudden Cardiac Death